AzTrials
AzTrials

Autism-Spectrum DisorderNCT04324099

Investigating the Specificity of Neural Correlates for Emotion Processing Deficits in Conduct Disorder and Autism Spectrum Disorders

An observational study of Autism-Spectrum Disorder and Conduct Disorder, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is 1. to investigate the differential and shared neural underpinnings of facial emotion processing within Conduct disorder (CD) and Autism-Spectrum disorder (ASD) and 2. to investigate the interaction between deficits in emotion processing and dysfunctional cognitive control processes. Read more about this study

Who is it for?
Ages 10 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Autism-Spectrum Disorder, Conduct Disorder
What is being tested?
neuroimaging session (with simultaneously acquired eye-tracking), Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)) and Social and Health Assessment (SAHA) questionnaire (for children)
How many people
120 participants
Where
1 siteSwitzerland
Study dates
16 Jul 2020to Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: German speaking children and adolescents (10-18 years of age) attended at the Kinder- und Jugendpsychiatrischen Klinik Basel (KJPK) and with a confirmed diagnosis of CD or ASD. Typically developing children will be recruited using leaflets (will be distributed in the KJPK clinics and in socioeconomically diversesecondary schools within the Canton of Basel-Stadt).

Who may be able to join

  • For all participants: age between 10 and 18 years and an intelligence quotient score of 70 or higher.
  • For patient groups: confirmed clinical diagnoses according to Diagnostic and Statistical Manual (DSM)-5 of CD or ASD (depending on the group), without comorbid depression or anxiety psychological disorders.

Who cannot join

  • For all participants: low intelligence (IQ<70, as they might otherwise not fully understand what they are expected to do inside the scanner), insufficient German language skills or any contraindications for MRI (e.g. pregnancy, any non-removable metal within the subjects' body, claustrophobia).
  • For patient groups: severe developmental disorders, comorbid depressive and/or anxiety disorders will also be excluded from the study since it was shown that these patients might have problems in attention allocation under emotional stimulation.
  • For typically developing participants: suspicion of an undiagnosed clinical disorder

Trial locations and contacts

1 site in 1 country.

Christina Stadler, Prof. Dr. med contact

+41 61 325 51 11

christina.stadler@upk.ch

Switzerland1 site, 1 recruiting
  • Department of Child and Adolescent Psychiatry, KJPK (UPK)

    Basel, 4002

    Christina Stadler, Prof. Dr. med, +41 61 325 51 11, christina.stadler@upk.ch

    Recruiting

Other trials in Switzerland

About this study

This study is

  1. to investigate the differential and shared neural underpinnings of facial emotion processing within Conduct disorder (CD) and Autism-Spectrum disorder (ASD) and
  2. to investigate the interaction between deficits in emotion processing and dysfunctional cognitive control processes.

Differences in emotion processing and the underlying neural underpinnings of such differences will be assessed by means of functional magnetic resonance imaging (fMRI) without any contrast agent, combined with adapted emotion processing paradigms and eye tracking techniques.

Being tested
neuroimaging session (with simultaneously acquired eye-tracking), Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)), Social and Health Assessment (SAHA) questionnaire (for children), Massachusetts Youth Screening Instrument (MAYSI-2) (for children), Interpersonal Reactivity Index (IRI) (for children)
Keywords
Callous-Unemotional traits, emotion processing deficits, dysfunctional cognitive control processes
Medical subject headings
Child Development Disorders, Pervasive, Conduct Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • neuroimaging session (with simultaneously acquired eye-tracking)Other

    neuroimaging session, including two functional neuroimaging paradigms (ca. 15-20 minutes each) and a short structural image acquisition (mprage) for coregistration. Functional Magnetic Brain Imaging (fMRI) and simultaneous eye-tracking data will be collected during the paradigms: 1) an emotion processing paradigm (adapted from Passamonti et al., 2010); and 2) an emotional Go/noGo paradigm (adapted from Hare et al., 2008).

  • Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ))Other

    The Childhood Trauma Questionnaire is a brief survey of six early traumatic experiences (death, divorce, violence, sexual abuse, illness or other), and assesses individual's understanding of their childhood trauma.

  • Social and Health Assessment (SAHA) questionnaire (for children)Other

    Self reported survey assessing social and mental health with four aspects of parenting determined (parental involvement, parental warmth, parental control, and inconsistency of parenting).

  • Massachusetts Youth Screening Instrument (MAYSI-2) (for children)Other

    The Massachusetts Youth Screening Instrument (MAYSI-2) is a screening instrument developed for detecting mental health needs in youth aged 12-17. Designed as a low-cost, easily administered tool, it screens for multiple issues and can be administered in 10-15 minutes. It is divided into seven scales composed of 52 questions that are designed to detect alcohol/drug use, angryirritable behavior, depression-anxiety, somatic complaints, suicide ideation, thought disturbance, and traumatic experience. Youths answer YES or NO concerning whether each item has been true for them "within the past few months.

  • Interpersonal Reactivity Index (IRI) (for children)Other

    The Interpersonal Reactivity Index is a measure of dispositional empathy that takes as its starting point the notion that empathy consists of a set of separate but related constructs. The instrument contains four seven-item subscales (seven Likert items each), each tapping a separate facet of empathy (Empathic Concern, Perspective Taking, Personal Distress, and Fantasy). The 28-item IRI contains four subscales

  • Youth Psychopathic Traits Inventory (YPI) (for children)Other

    self-report screening measures to assess psychopathic traits in youth assessing 10 core personality traits associated with the construct (grandiosity, lying, manipulation, callousness, unemotionality, impulsivity, irresponsibility, dishonest charm, remorselessness, and thrill seeking). Each item is scored on an ordinal 4-point Likert scale (1 = Does not apply at all, to 4 = Applies very well). Higher scores reflect an increased presence of psychopathic traits.

  • Reactive Proactive Questionnaire (RPQ) (for children)Other

    The Reactive-Proactive Questionnaire (RPQ) scores (0 (never), 1 sometimes, 2 (often)) for proactive aggression items and reactive items. Proactive and reactive scale scores are summated to obtain total aggression scores.

  • Emotion Regulation Questionnaire (for children)Other

    10-item scale designed to measure respondents' tendency to regulate their emotions in two ways: (1) Cognitive Reappraisal and (2) Expressive Suppression. Respondents answer each item on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree)

  • Basic Empathy Scale (BES) (for children)Other

    The Basic Empathy Scale (BES) measures 20 items (affective and cognitive empathy) on a Five-point Likert-type scale.

  • Pubertal Development Scale (PDS) (for children)Other

    self-report measure of physical development which has been shown to be correlated with measures of pubertal development derived from physical examination. Responses are coded on 4-point scales (1 = no development and 4 = completed development). For girls, a yes-no question about onset of menarche is weighted more heavily (1 = no and 4 = yes). For both genders, ratings are then averaged to create an overall score for physical maturation.

  • Alabama Parenting Questionnaire (APQ) (for parents)Other

    The APQ measures five dimensions of parenting that are relevant to the etiology and treatment of child externalizing problems: (1) positive involvement with children, (2) supervision and monitoring, (3) use of positive discipline techniques, (4) consistency in the use of such discipline and (5) use of corporal punishment (42 self-reported responses, rated on a 5-point Likert scale- 1 (never) to 5 (always) for both child and parent forms)

  • Inventory of Callous Unemotional Traits (ICU) (for parents)Other

    24-item questionnaire designed to provide a comprehensive assessment of callous and unemotional traits.The ICU has three subscales: Callousness, Uncaring, and Unemotional. The ICU is made up of statements with a 4-point Likert scale, ranging from 0 (Not at all true) to 3 (Definitely True), with higher scores indicating greater CU traits.

  • Child Behavior Checklist (CBCL) (for parents)Other

    The eight empirically-based syndrome scales are:

    1. Aggressive Behavior
    2. Anxious/Depressed
    3. Attention Problems
    4. Rule-Breaking Behavior
    5. Somatic Complaints
    6. Social Problems
    7. Thought Problems
    8. Withdrawn/Depressed. Higher scores indicate greater Problems.
  • Griffith Empathy Measure (GEM) (for parents)Other

    self-report 23-item measure of empathy in which the respondent answers each item on a nine-point Likert scale from strongly disagree to strongly agree

  • Social Responsiveness Scale (SRS) (for parents)Other

    Social Responsiveness Scale (SRS) measures social ability of children from 4 years to 18 years old. It is used primarily with individuals with Autism Spectrum Disorder (ASD), family members of individuals with ASD, and others who have social impairments. Parent or teacher questionnaire (65 items on a 4-point Likert scale). High scores are associated with more severe social impairments.

Study groups in NCT04324099
Study groupRoleWhat they receive
Conduct disorderchildren and adolescents with CD
Receives: Other: neuroimaging session (with simultaneously acquired eye-tracking); Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)); Other: Social and Health Assessment (SAHA) questionnaire (for children); Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children); Other: Interpersonal Reactivity Index (IRI) (for children); Other: Youth Psychopathic Traits Inventory (YPI) (for children); Other: Reactive Proactive Questionnaire (RPQ) (for children); Other: Emotion Regulation Questionnaire (for children); Other: Basic Empathy Scale (BES) (for children); Other: Pubertal Development Scale (PDS) (for children); Other: Alabama Parenting Questionnaire (APQ) (for parents); Other: Inventory of Callous Unemotional Traits (ICU) (for parents); Other: Child Behavior Checklist (CBCL) (for parents); Other: Griffith Empathy Measure (GEM) (for parents); Other: Social Responsiveness Scale (SRS) (for parents)
Autism-Spectrum disorderchildren and adolescents with ASD
Receives: Other: neuroimaging session (with simultaneously acquired eye-tracking); Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)); Other: Social and Health Assessment (SAHA) questionnaire (for children); Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children); Other: Interpersonal Reactivity Index (IRI) (for children); Other: Youth Psychopathic Traits Inventory (YPI) (for children); Other: Reactive Proactive Questionnaire (RPQ) (for children); Other: Emotion Regulation Questionnaire (for children); Other: Basic Empathy Scale (BES) (for children); Other: Pubertal Development Scale (PDS) (for children); Other: Alabama Parenting Questionnaire (APQ) (for parents); Other: Inventory of Callous Unemotional Traits (ICU) (for parents); Other: Child Behavior Checklist (CBCL) (for parents); Other: Griffith Empathy Measure (GEM) (for parents); Other: Social Responsiveness Scale (SRS) (for parents)
typically developing adolescentstypically developing adolescents
Receives: Other: neuroimaging session (with simultaneously acquired eye-tracking); Other: Questionnaire (for children) assessing traumatic experiences (Childhood trauma questionnaire (CTQ)); Other: Social and Health Assessment (SAHA) questionnaire (for children); Other: Massachusetts Youth Screening Instrument (MAYSI-2) (for children); Other: Interpersonal Reactivity Index (IRI) (for children); Other: Youth Psychopathic Traits Inventory (YPI) (for children); Other: Reactive Proactive Questionnaire (RPQ) (for children); Other: Emotion Regulation Questionnaire (for children); Other: Basic Empathy Scale (BES) (for children); Other: Pubertal Development Scale (PDS) (for children); Other: Alabama Parenting Questionnaire (APQ) (for parents); Other: Inventory of Callous Unemotional Traits (ICU) (for parents); Other: Child Behavior Checklist (CBCL) (for parents); Other: Griffith Empathy Measure (GEM) (for parents); Other: Social Responsiveness Scale (SRS) (for parents)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. difference between groups (children and adolescents with CD, ASD and typically developing adolescents) in neural activity

    difference between groups in neural activity as measured by Blood Oxygen Level Dependent (BOLD) signal during emotion processing using a priori defined regions of interest (ROIs) including the insula, amygdala, and ventromedial prefrontal Cortex in fMRI

    Measured: fMRI imaging Day 1

Secondary outcomes (1)
  1. Emotion processing task (fMRI)

    Emotion processing task (fMRI): measures of eye gaze collected by eye-tracking

    Measured: fMRI imaging Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2020
  2. Study start16 Jul 2020
  3. Primary completionApr 2023 (estimated)
  4. Study completionJun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04324099
Sponsor's protocol ID
2019-02386;pk17Stadler
Other IDs
2019
Status last verified
Feb 2022
First submitted
24 Mar 2020
Last updated
2 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Autism-Spectrum Disorder and Conduct Disorder, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Christina Stadler, Prof. Dr. med (+41 61 325 51 11, christina.stadler@upk.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

difference between groups (children and adolescents with CD, ASD and typically developing adolescents) in neural activity (time frame: fMRI imaging Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in